Venker Eric

President &Immunovant CEO | President &COO | Chief Operating Officer

1 company

Weak

Trades Analyzed

12M Win Rate

17.5%

Avg 3M Return

-12.1%

Avg 12M Return

-39.7%

Venker Eric is a President &Immunovant CEO at Roivant Sciences Ltd.. Recent SEC Form 4 filings include 0 buys and 22 sells.

Estimated insider holdings value: $47.1M based on current market prices.

Holdings by Company

ROIVApr 20, 2026

Current Shares1.65M

Value$47.05M

Net Activity-12,577,626

Bought: 0Sold: 12.58M

Showing 10 filings (page 4)

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Aug 2, 2023	ROIV Roivant Sciences Ltd.	Chief Operating Officer	Sale+OE	195,166	$11.91	$2,324,221.18	-9.4%	-26.8%	-10.1%
Jul 27, 2023	ROIV Roivant Sciences Ltd.	Chief Operating Officer	Sale+OE	125,534	$10.91	$1,369,812.28	-6.2%	-20.9%	0.0%
Jul 24, 2023	ROIV Roivant Sciences Ltd.	President &COO	Sale+OE	374,466	$11.19	$4,189,880.04	-16.2%	-19.9%	+2.6%
Jun 9, 2023	ROIV Roivant Sciences Ltd.	President &COO	Sale+OE	299,585	$9.91	$2,968,875.29	-18.5%	+16.7%	+4.4%
May 23, 2023	ROIV Roivant Sciences Ltd.	President &COO	Sale+OE	415	$9.85	$4,087.75	-	+16.7%	+20.2%
May 9, 2023	ROIV Roivant Sciences Ltd.	President &COO	Sale+OE	238,724	$9.23	$2,203,422.52	-26.1%	+20.0%	+19.6%
May 8, 2023	ROIV Roivant Sciences Ltd.	President &COO	Sale+OE	150,044	$8.56	$1,283,924.98	-10.0%	+25.4%	+27.0%
May 3, 2023	ROIV Roivant Sciences Ltd.	President &COO	Sale+OE	288,989	$8.40	$2,427,128.91	-12.5%	+41.4%	+33.2%
Apr 28, 2023	ROIV Roivant Sciences Ltd.	President &COO	Sale+OE	222,243	$8.55	$1,899,190.91	-9.9%	+26.3%	+29.0%
Jan 5, 2023	ROIV Roivant Sciences Ltd.	President &COO	Sell	24,037	$8.02	$192,776.74	-3.2%	-12.7%	+38.5%